KANGO SUJAY 4
4 · ACCELERON PHARMA INC · Filed Sep 27, 2021
Insider Transaction Report
Form 4
KANGO SUJAY
SVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2021-09-27−5,000→ 25,000 totalExercise: $40.61Exp: 2028-03-01→ Common Stock (5,000 underlying) - Sale
Common Stock
2021-09-27$175.00/sh−5,000$875,000→ 18,509 total - Exercise/Conversion
Common Stock
2021-09-27$40.61/sh+5,000$203,050→ 23,509 total
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The shares of common stock underlying this stock option award vested as to 25% of the shares on the first anniversary of February 12, 2018 and the remaining shares vest in equal quarterly installments over the following three years thereafter.